The FDA and Congress are moving fast to ban all flavors used in vaping devices.
The IPI – Are We All Socialists Now?
Adopting these policies would validate socialized medicine schemes like price controls and rationing.
SCOTUS Says “No” to Expediting Review of Obamacare Lawsuit
On Tuesday, January 21, SCOTUS issued an Orders List for pending cases.
Medicaid: The Feds Have Failed To Stop the Waste and Mismanagement, Let The States Try
Medicaid is losing billions to waste, fraud, and abuse, and the program is crushing state budgets The feds haven’t been able to fix it. Let the states try.
Sen. Elizabeth Warren Offers More Dangerous Healthcare Ideas
Essentially it is Speaker Nancy Pelosi’s (D-Calif.) socialistic drug discount plan, H.R. 3, on steroids.
U.S. Fifth Circuit Court of Appeals Agrees: Obamacare Individual Mandate is Unconstitutional
No one who purchases health insurance in an Obamacare exchange will lose their health insurance.
USMCA Steps Back on Intellectual Property Protection
The administration and Congress should support IP protection in trade deals that respect and adhere as closely as possible to U.S. laws.
Let’s Not Import Bad Ideas Like International Price Indexing
How long do you think television companies would stay in business if the government told them to charge $200 for a TV even though the TV costs $250 to manufacture? Not very long, but that is exactly what the socialists in Congress want to do with prescription drugs. They want to use “international price indexing” […]
Congress can Prevent Taxpayers from Getting Hit with Health Insurance Tax
With only a couple weeks left on the 2019 legislative calendar and much of the air on Capitol Hill being consumed by impeachment, Congress is missing out on a painless bipartisan victory that could save taxpayers hundreds of dollars in health insurance premiums. The Health Insurance Tax (HIT), a product of the Affordable Care Act, […]
CBO Releases the “Savings” Expected from Speaker Pelosi’s Drug Pricing Bill
H.R. 3 exerts so much government authority over the pharmaceutical industry.